Vertex Pharmaceuticals (VRTX) EPS (Basic) (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted quarterly EPS (Basic) of $4.06 for Q1 2026, up 61.34% year-over-year from $2.52 in Q1 2025, and down 12.86% on a QoQ basis from $4.66 in Q4 2025.
Vertex Pharmaceuticals (VRTX) EPS (Basic) (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals (VRTX) has reported EPS (Basic) for 18 consecutive years, with $4.06 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 61.34% year-over-year to $4.06; the TTM figure through Mar 2026 stood at $17.07 (up 543.53% YoY), while the FY2025 annual figure was $15.46, up 844.44% from the prior year.
- EPS (Basic) came in at $4.06 for Q1 2026 at Vertex Pharmaceuticals, down from $4.66 in the prior quarter.
- The five-year high for EPS (Basic) was $4.66 in Q4 2025, with the low at -$13.92 in Q2 2024.
- Average EPS (Basic) over 5 years is $2.61, with a median of $3.63 recorded in 2022.
- Across the five-year window, EPS (Basic) soared 1124.3% in 2022 and slumped 491.83% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at $3.2 in 2022, then climbed by 17.57% to $3.76 in 2023, then retreated by 5.83% to $3.54 in 2024, then jumped by 31.58% to $4.66 in 2025, then dropped by 12.86% to $4.06 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $4.06, $4.66, and $4.24 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | 0.00 |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | 0.00 |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 0.16 |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 4.06 |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | - |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 6.99 |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 0.01 |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 1.55 |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | -2.29 |
| 10 | Moderna | 28.64 Bn | 23.43 Bn | -566.00 Mn | -3.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.06 |
| Dec 31, 2025 | 4.66 |
| Sep 30, 2025 | 4.24 |
| Jun 30, 2025 | 4.02 |
| Mar 31, 2025 | 2.52 |
| Dec 31, 2024 | 3.54 |
| Sep 30, 2024 | 4.05 |
| Jun 30, 2024 | -13.92 |
| Mar 31, 2024 | 4.26 |
| Dec 31, 2023 | 3.76 |
| Sep 30, 2023 | 4.01 |
| Jun 30, 2023 | 3.55 |
| Mar 31, 2023 | 2.72 |
| Dec 31, 2022 | 3.20 |
| Sep 30, 2022 | 3.63 |
| Jun 30, 2022 | 3.17 |
| Mar 31, 2022 | 2.99 |
| Dec 31, 2021 | 2.99 |
| Sep 30, 2021 | 3.30 |
| Jun 30, 2021 | 0.26 |